The VA's Pack of Lies

  • by: |
  • 02/08/2007
The VA is in full retreat about it's penny-wise pound foolish formulary approach. It presented a power point presentation at an AEI summit on price controls in Medicare and then exported the propaganda to a meeting on drug formularies in Helsinki which is ironically the namesake of protocols designed to protect patients from getting screwed without their knowledge.

http://www.aei.org/events/eventID.1447,filter.all/event_detail.asp

Here's a breakdown of the myth's and fact's that the VA is now pushing:

1. VA offers more individual drugs that Part D

Fact: The VA offers more different varieties of the SAME drug but (formulations, doses, etc). Part D offers more unique new molecular entitites.

2. The VA formulary is not restrictive

Fact: The VA quotes a report written in 1998 (published in 2000) before it began an effort to push prescribers to adhere more tightly to closed formularies.

3. VA system participants live longer lives

Fact: The VA outright lies and uses a chart that is an outright mischaracterization of Frank Lichtenberg's study Older Drugs, Shorter Lives? An Examination of the Health Effects of the Veterans Health Administration Formulary (which I commissioned when at the Manhattan Institute).

http://www.manhattan-institute.org/html/mpr_02_f4.htm

Frank's chart is above. As you can see, he never claims that people in the VA don't live longer than people not in the VA. And he explains why in a footnote to the paper.

While there are some reasons to expect the mean value of Et to be lower than the mean value of the life expectancy of all U.S. males at birth-serving in the military may impair one's future health-there are other reasons to expect it to be greater. Et is based on a population of individuals who have been veterans, i.e., who lived long enough to serve in the armed forces (e.g., did not die in infancy) and who survived serving in the armed forces. It would be more appropriate to compare Et with the life expectancy of all U.S. males at age twenty, for example. Such data are available for some years (it was 73.25 for 1989-1991 and 75.6 in 2002) but are not available annually (Arias, 2004, Table 11).

What Lichtenberg shows is that after the VA formulary was introduced, the increase in life expectancy at any given period declined. He did not compared differences in LE.

But that's not good enough for the VA. It had to fudge the chart itself. So it introduced a chart that compared periodic life expectancy of vets to life expectancy of all Americans at birth in a way that erases the decline in life expectancy.

4. The VA claims it provides better pharmaceutical care.

Fact. There are many health care services that the VA does extremely well. However to the extent that the VA itself seeks to reduce hospitalizations and prevent disease the use of the best pharmaceuticals is critical to maximizing these goals. The failure of the VA to devote its considerable health IT resources to determine what the best drug for the right patient is reflects an insular and outdated view of medicine. It is very good at achieving better results on process measures relative to some commercial health plans and some evidence that the care it provides is a good as private hospitals. But the VA refuses to allow outside researchers examine the impact of formulary restrictiveness on patient outcomes and total health care costs.

5. The VA doesn't use mail order pharmacy.

Fact: According to GAO and the VA itself, the VA fills 83 percent of its prescriptions through mail order.

6. The VA claims newer is not always better

Fact: Does that mean the VA has more older drugs than Medicare Part D. Does that mean older is always better? In fact, most new drugs are associated with an increase in well-being and clinical improvement with some subpopulation. And in the case of the VA it has not added drugs even the FDA regarded as priority medicines, drugs that have a significant therapeutic value, to its formulary.

7. The VA does not have have a three year wait on all new drugs.

Fact: The VA is right on this count. Sort of. It generally waits a year. Or longer. It was only recently, under pressure from Part D, that it began adding new medicines in a timely fashion. It still hasn't added many new cancer drugs.

8. There have not been 1 million Part D defections

Fact: No defections. But 2 million have signed up for Part D in addition to the VA benefits they receive. Why can't the VA just be honest. There are plenty of people who double dip...

9. Drugs not on the VA formulary are in fact available.

No one said they are unavailable. That's a VA strawman. Drugs not on the formulary are just hard to get. It takes anywhere from 3 days to a week to get an answer. Often you have to try a drug for a while before you can ask for a change, which means traveling to see a doctor. As a result, even the VA's own numbers show that less than 5-10 percent of its patients get medicines like Lipitor, Ambien or Protonix.

10. Doctors are satisfied with the restrictive formularies.

Fact. Fully a third of all doctors who took the time to respond to a VA run survey complained it took too long to get requests answered. (Provider perceptions of pharmacy management: lessons from the military health system.
Med Care. 2004 Apr;42(4):361-6. )

Another survey (also self-selected respondents) found that 35 percent of doctors believed the national formulary restricted access to important drugs. Glassman PA, Good CB, Kelley ME, Bradley M, Valentino M, Ogden J, Kizer KW. Related Articles, Links
Free Full Text Physician perceptions of a national formulary.
Am J Manag Care. 2001 Mar;7(3):241-51.
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog